Cationic vesicles based on biocompatible diacyl glycerol-arginine surfactants: Physicochemical properties, antimicrobial activity, encapsulation efficiency and drug release

Colloids and Surfaces B: Biointerfaces

Volumn 120, Issue , 2014, Pages 160-167

  Tavano, L ^a   Pinazo, A ^b   Abo Riya, M ^c   Infante, M R ^b   Manresa, M A ^d   Muzzalupo, R ^a   Perez L ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^c BENHA UNIVERSITY   (Egypt)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

5 Fluorouracil; Antimicrobial activity; Ciprofloxacin; Diacyl glycerol arginine surfactants; Release; Vesicles

Indexed keywords

ANTIBIOTICS; ARGININE; BACTERIA; BIOCOMPATIBILITY; ENCAPSULATION; ESCHERICHIA COLI; GLYCEROL;

5-FLUOROURACIL; ANTI-MICROBIAL ACTIVITY; CIPROFLOXACIN; RELEASE; VESICLES;

CATIONIC SURFACTANTS;

1,2 DIDECANOYL 3 O (N ARGINYL) RAC GLYCEROL; 1,2 DIMIRISTOYL 3 O (N ARGINYL) RAC GLYCEROL; CIPROFLOXACIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; FLUOROURACIL; SURFACTANT; UNCLASSIFIED DRUG; 1,2-DIACYLGLYCEROL; ANTIINFECTIVE AGENT; ARGININE; BIOMATERIAL; CATION; DIACYLGLYCEROL; LIPOSOME;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CATION TRANSPORT; CONTROLLED STUDY; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; ESCHERICHIA COLI; HYDROPHOBICITY; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; LIGHT SCATTERING; NONHUMAN; PERMEABILITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; ZETA POTENTIAL; BACTERIA; CHEMISTRY; DRUG EFFECTS; HYDRODYNAMICS; MICROBIAL SENSITIVITY TEST; PARTICLE SIZE; PH; STATIC ELECTRICITY; SYNTHESIS;

ANTI-INFECTIVE AGENTS; ARGININE; BACTERIA; BIOCOMPATIBLE MATERIALS; CATIONS; CIPROFLOXACIN; DIGLYCERIDES; DRUG LIBERATION; FLUOROURACIL; HYDRODYNAMICS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICROBIAL SENSITIVITY TESTS; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; STATIC ELECTRICITY; SURFACE-ACTIVE AGENTS;

EID: 84901792713     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.04.009     Document Type: Article

References (58)

1. Greco F., Vicent M.J. Adv. Drug Delivery Rev. 2009, 6:1203.
2. Schreier H., Levy M., Mihalko P. J. Controlled Release 1987, 5:187.
3. Tavano L., Alfano P., Muzzalupo R., de Cindio B. Colloids Surf. 2011, 87:333.
4. Azmin M.N., Florence A.T., Handajani V.R., Stuart J.F.B., Vanlerberghe G., Wittakar J.S. J. Pharm. Pharmacol. 1985, 37:237.
5. Uchegbu I.F., Vyas S.P. Int. J. Pharm. 1998, 172:33.
6. Lian T., Hok R.J.Y. J. Pharm. Sci. 2001, 90:667.
7. Antunes F.E., Gentile L., Oliviero C., Tavano L., Ranieri G.A. Colloids Surf. 2011, 87:42.
8. Yimei J., Joly H., Omri A. Int. J. Pharm. 2008, 359:254.
9. Bakker-Woudenberg I.A.J.M., Storm G., Woodle M.C. J. Drug Targeting 1994, 2:363.
10. Andresen T.L., Jensen S.S., Jørgensen K. Prog. Lipid Res. 2005, 44:68.
11. Storm G., Van Etten E.W.M. Eur. J. Clin. Microbiol. Infect. Dis. 1997, 16:64.
12. Vieira D.B., Carmona-Ribeiro A.M. J. Antimicrob. Chemother. 2006, 58:760.
13. Wu J., Lee A., Lu Y., Lee R.J. Int. J. Pharm. 2007, 337:329.
14. Hu F.Q., Zhang Y.Y., You J., Yuan H., Du.Y.Z. Mol. Pharmaceutics 2012, 9:246.
15. Pérez L., Pinazo A., Vinardell P., Clapés P., Angelet M., Infante M.R. New J. Chem. 2002, 26:1221.
16. Lozano N., Perez L., Pons R., Pinazo A. Amino Acids 2011, 40:721.
17. Lozano N., Perez L., Pons R., Luque-Ortega J.R., Fernandez-Reyes M., Rivas L., Pinazo A. Colloids Surf. 2008, 319:196.
18. Colomer A., Pinazo A., García M.T., Mitjans M., Vinardell M.P., Infante M.R., Martínez V., Pérez L. Langmuir 2012, 28:5900.
19. Bangham A.D., Horne R.W. J. Mol. Biol. 1964, 8:660.
20. Fenton R.R., Easdable W.J., Meng H., Omara E.S.M., Mckeage M.J., Russel P.J., Hambley T.W. J. Med. Chem. 1997, 40:1090.
21. Lawrie A.S., Albanyan A., Cardigan R.A., Mackie J., Harrison P. Vox Sang. 2009, 96:206.
22. Provencher S.W. Comput. Phys. Commun. 1982, 27:229.
23. Tavano L., Muzzalupo R., Mauro L., Pellegrino M., Andò S., Picci N. Langmuir 2013, 29:12638.
24. Muzzalupo R., Tavano L., La Mesa C. Int. J. Pharm. 2013, 458:224.
25. Jones R.N., Barry A.L., Gavan T.L., Washington J.A. Manual of Clinical Microbiology 1985, American Society for Microbiology, Washington, DC. fourth ed. E.H. Lennette, A. Ballows, W.J. Hauser, H.J. Shadomy (Eds.).
26. Benavides T., Mitjans M., Martínez V., Clapés P., Infante M.R., Clothier R.H., Vinardell M.P. Toxicology 2004, 197:229.
27. Aiello C., Andreozzi P., La Mesa C., Risuleo G. Colloids Surf. 2010, 78:149.
28. Cortesi R., Esposito E., Menegatti E., Gambari R., Nastruzzi C. Int. J. Pharm. 1996, 139:69.
29. Crowston J.G., Wang X.Y., Khaw P.T., Zoellner H., Healey P.R. Invest. Ophthalmol. Visual Sci. 2006, 47:946.
30. Pinazo A., Perez L., Infante M.R., Pons R. Phys. Chem. 2004, 6:1475.
31. Cortesi R., Esposito E., Corradini F., Sivieri E., Drechsler M., Rossi A., Scatturin A., Menegatti E. Int. J. Pharm. 2007, 339:52.
32. Hao Y., Zhao F., Yi N., Yang Y., Li K. Int. J. Pharm. 2002, 244:73.
33. Uhríkova D., Hanulova M., Funari S.S., Lacko I., Devínsky F., Balgavy P. Biophys. Chem. 2004, 111:197.
34. Uchegbu I.F. Synthetic Surfactant Vesicles: Niosomes and Other Non-phospholipid Vesicular Systems 2000, Harwood Academic, London.
35. Manosroi A., Wongtrakul P., Manosroi J., Midorikawa U., Hanyu Y., Yuasa M., Sugawara F., Sakai H., Abe M. Int. J. Pharm. 2005, 298:13.
36. Zhao L., Feng S. J. Colloid Interface Sci. 2005, 285:326.
37. Presti R.T., Pace R.J., Chan S.I. Biochemistry 1982, 21:3831.
38. Sobral C., Soto M., Carmona-Riberio A.M. Chem. Phys. Lipids 2008, 152:38.
39. Bombelli C., Bordi F., Ferro S., Giansanti L., Jori G., Mancini G., Mazzuca C., Monti D., Ricchelli F., Sennato S., Venanzi M. Mol. Pharmaceutics 2008, 5:672.
40. Bakker-Woudenberg I.A.J.M. Int. J. Antimicrob. Agents 2002, 19:299.
41. Hardman J.G., Limburd L.E. The Pharmacological Basis of Therapeutics 1996, McGraw-Hill, New York, NY. Goodman, Gilman's (Eds.).
42. Montero M.T., Saiz D., Sitges R., Vatzquez J.L., Hernindez-Borrell J. Int. J. Pharm. 1996, 138:113.
43. Namdeo A., Jain N.K. J. Microencapsulation 1999, 16:731.
44. Appelbaum P.C., Hunter P.A. Int. J. Antimicrob. Agents 2000, 16:5.
45. Trafny E.A., Stepinska M., Antos M., Grzybowski J. Antimicrob. Agents Chemother. 1995, 39:2645.
46. Muzzalupo R., Tavano L., Trombino S., Cassano R., Picci N., La Mesa C. Colloids Surf. 2008, 64:200.
47. Sharma A., Sharma U.S. Int. J. Pharm. 1997, 154:123.
48. Gubernator J., Drulis-Kawa Z., Dorotkiewicz-Jach A., Doroszkiewicz W., Kozubek A. Lett. Drug Des. Discovery 2007, 4:297.
49. Lutwyche P., Cordeiro C., Wiseman D.J., St-Louis M., Uh M., Hope M.J., Webb M.S., Brett Finlay B. Antimicrob. Agents Chemother. 1998, 42:2511.
50. Sasaki H., Matsukawa Y., Hashida M., Sezaki H. Int. J. Pharm. 1987, 36:147.
51. Liang M.T., Davies N.M., Toth I. Int. J. Pharm. 2005, 301:247.
52. Jukanti R., Gaddam P., Jalagam M., Bandari S. J. Dispersion Sci. Technol. 2011, 32:935.
53. du Plessis J., Ramachandran C., Weiner N., Muller D.G. Int. J. Pharm. 1996, 127:273.
54. Carrera C., Martorell J., Freixas J., Hernández J. Drug Dev. Ind. Pharm. 1993, 19:1709.
55. Glavas-Dodov M., Fredro-Kumbaradzi E., Goracinova K., Simonoska M., Calis S., Trajkovic-Jolevska S., Hincal A.A. Int. J. Pharm. 2005, 291:79.
56. Kulkarni S.B., Betageri G.V., Singh M. J. Microencapsulation 1995, 12:229.
57. Kirby C., Gregoriadis G. Nat. Biotechnol. 1984, 2:979.
58. Pérez L., Torres J.L., Manresa A., Solans C., Infante M.R. Langmuir 1996, 12:5296.